Literature DB >> 20424418

Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial.

Theo C J Sas1, Maria A J de Ridder, Jan M Wit, Joost Rotteveel, Wilma Oostdijk, H Maarten Reeser, Barto J Otten, Sabine M P F de Muinck Keizer-Schrama.   

Abstract

AIM: To investigate the effect of 2 growth hormone (GH) doses on adult height (AH) in GH deficiency (GHD).
METHODS: A multicenter, randomized, controlled dose-response trial compared attained AH minus target height (TH) between children receiving 0.7 mg/m(2)/day biosynthetic GH (approx. 0.025 mg/kg/day) or 1.4 mg/m(2)/day (approx. 0.050 mg/kg/day). The patients enrolled in the trial were 20 'naïve' GHD children (had not received GH before) and 15 'transfer' GHD children (already on GH for at least 1 year).
RESULTS: In the naïve group, the mean +/- SD AH minus TH was -5.3 +/- 6.1 and -2.2 +/- 6.9 cm in patients on 0.7 and 1.4 mg/m(2)/day, respectively (mean +/- SE difference 3.1 +/- 2.9; p = 0.3). In the transfer group, the mean +/- SD AH minus TH was -4.4 +/- 6.4 and +0.6 +/- 7.0 cm in patients on 0.7 and 1.4 mg/m(2)/day, respectively (mean +/- SE difference 5.0 +/- 3.5; p = 0.17). Spontaneous puberty started 1.1 years earlier in children on 1.4 compared to 0.7 mg/m(2)/day. Induction of puberty was more often delayed in transfer children on 0.7 than on 1.4 mg/m(2)/day.
CONCLUSION: In our GHD patients, AH was 4-5 cm less than TH in patients on 0.7 mg/m(2)/day GH, while it was 0-2 cm less in patients on 1.4 mg/m(2)/day GH, but this difference did not reach statistical significance, probably due to limited numbers of patients, considerable variability in the growth response and earlier spontaneous puberty and pubertal induction in the children on 1.4 mg/m(2)/day. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424418     DOI: 10.1159/000281323

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  10 in total

Review 1.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

2.  Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®.

Authors:  Peter A Lee; John Germak; Robert Gut; Naum Khutoryansky; Judith Ross
Journal:  Int J Pediatr Endocrinol       Date:  2011-07-07

3.  Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program.

Authors:  Judith L Ross; Peter A Lee; Robert Gut; John Germak
Journal:  Int J Pediatr Endocrinol       Date:  2015-01-15

4.  Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

Authors:  Elena Lundberg; Berit Kriström; Bjorn Jonsson; Kerstin Albertsson-Wikland
Journal:  BMC Endocr Disord       Date:  2015-12-18       Impact factor: 2.763

5.  Adherence and long-term growth outcomes: results from the easypod connect observational study (ECOS) in paediatric patients with growth disorders.

Authors:  Ekaterina Koledova; George Stoyanov; Leroy Ovbude; Peter S W Davies
Journal:  Endocr Connect       Date:  2018-07-05       Impact factor: 3.335

6.  Growth hormone therapy in children born small for gestational age: results from the ANSWER program.

Authors:  Robert Rapaport; Peter Lee; Judith Ross; Paul Saenger; Vlady Ostrow; Giuseppe Piccoli
Journal:  Endocr Connect       Date:  2018-08-23       Impact factor: 3.335

7.  Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.

Authors:  Elena Lundberg; Berit Kriström; Hichem Zouater; Anna Deleskog; Charlotte Höybye
Journal:  BMC Endocr Disord       Date:  2020-04-29       Impact factor: 2.763

Review 8.  Should Skeletal Maturation Be Manipulated for Extra Height Gain?

Authors:  Jan M Wit
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-16       Impact factor: 5.555

Review 9.  Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.

Authors:  Michael B Ranke
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

10.  Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study.

Authors:  Jiajia Chen; Yan Zhong; Haiyan Wei; Shaoke Chen; Zhe Su; Lijun Liu; Liyang Liang; Ping Lu; Linqi Chen; Ruimin Chen; Shining Ni; Xinli Wang; Li Li; Yunfeng Wang; Xu Xu; Yanfeng Xiao; Hui Yao; Geli Liu; Runming Jin; Bingyan Cao; Di Wu; Chang Su; Wenjing Li; Miao Qin; Xiaoqiao Li; Xiaoping Luo; Chunxiu Gong
Journal:  BMC Endocr Disord       Date:  2022-08-09       Impact factor: 3.263

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.